Treatment regimens for multiple myeloma have expanded significantly over the last decade and have improved outcomes in patients. This expansion has created knowledge and practice gaps among community oncology providers in administration protocol and adverse event (AE) management.
The goal of this project was to assess practice patterns, monitoring and management of treatment-related AEs, supportive care services, and barriers to treatment for patients with multiple myeloma.
For more information on this study contact Mary Stanley, LMSW, PMP at mstanley@accc-cancer.org.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
